February 2017
J7209 replaces J7199 when billing for Nuwiq® (simoctocog alfa), antihemophilic factor (recombinant)
The Centers for Medicare & Medicaid Services has established a permanent procedure code for Nuwiq®, effective Jan. 1, 2017.
All services from Sept. 15, 2015, through Dec. 31, 2016, will continue to be reported with code J7199. All services performed on and after Jan. 1, 2017, must be reported with J7209.
Nuwiq (simoctocog alfa), antihemophilic factor (recombinant) continues to be covered for the FDA-approved indications as establisted on Sept. 15, 2015.
Pharmacy doesn’t require preauthorization of this drug.
|